Results 271 to 280 of about 212,078 (304)
Some of the next articles are maybe not open access.
Angiotensin-Converting Enzyme Inhibitor Angioedema
The Journal of Emergency Medicine, 2012*Department of Emergency Medicine, University of Michigan/St. Joseph Mercy Emergency Medicine Residency, Ann Arbor, Michigan, and †Department of Emergency Medicine, University of Michigan Health System, Ann Arbor, Michigan Reprint Address:Michaelina R. Bolton, MD, Department of Emergency Medicine, University of Michigan Health System, 1500 E.
Michaelina R, Bolton +1 more
openaire +2 more sources
The angiotensin converting enzyme (ACE)
The International Journal of Biochemistry & Cell Biology, 2003Angiotensin converting enzyme 1, found widely throughout the animal kingdom, is an integral membrane bound protein whose active sites are directed to the extracellular spaces. Two isoforms are expressed in mammals, a single domain germinal isoform required for male fertility, and a double domain somatic isoform which has a key role in the renin ...
openaire +2 more sources
Oral angiotensin-converting-enzyme inhibitors
American Journal of Health-System Pharmacy, 1997The pharmacology, pharmacokinetics, clinical uses, adverse effects, drug interactions, dosage, cost, and therapeutic interchange of oral angiotension-converting-enzyme (ACE) inhibitors are reviewed. ACE inhibitors attenuate the formation of angiotension II and may lead to the accumulation of kinins.
openaire +2 more sources
Angiotensin-Converting Enzyme Inhibition
Journal of Cardiovascular Pharmacology, 1985Compelling arguments can be made for a local, intrarenal role as angiotensin's first action in phylogeny, with additional cardiovascular and endocrine responses arising later. Perhaps for that reason the vascular bed of the kidney is especially responsive to angiotensin II.
openaire +2 more sources
Angiotensin‐Converting Enzyme in Sarcoidosis
Acta Medica Scandinavica, 1979ABSTRACT Using a spectrophotometric assay with l‐hippuryl‐l‐histidyl‐l‐leucine as substrate, s‐angio‐tensin‐converting enzyme (SACE) was determined in 85 sarcoidosis patients, 116 healthy controls and 150 patients with various non‐sarcoid diseases. The controls showed no sex or age variation and had SACE levels of 24.4±6.2 U/ml (mean ± 1 S.D.), giving ...
openaire +2 more sources
Angiotensin-Converting Enzyme (ACE) Inhibitors
2015Angiotensin converting enzyme inhibitors represent a new class of agents which were designed to retain only that unique property. Because of this inhibition, administration of these agents results in the significant reduction of elevated blood pressure of various etiologies and in the amelioration of symptoms associated with congestive heart failure ...
Daniel Thomas Ginat, Jason M. Johnson
openaire +1 more source
Angiotensin Converting Enzyme (ACE) Inhibitors
Annual Review of Pharmacology and Toxicology, 1982Angiotensin converting enzyme inhibitors represent a new class of agents which were designed to retain only that unique property. Because of this inhibition, administration of these agents results in the significant reduction of elevated blood pressure of various etiologies and in the amelioration of symptoms associated with congestive heart failure ...
openaire +2 more sources
Enzymes in Sarcoidosis: Angiotensin-Converting-Enzyme (ACE)
Clinics in Laboratory Medicine, 1989Measurement of serum angiotensin-converting-enzyme (SACE) is the most useful test for diagnosing and monitoring disease activity in sarcoidosis. Because elevated levels of SACE are not specific for sarcoidosis, other conditions in which SACE levels are also elevated are examined.
openaire +2 more sources
Metal–Organic Framework-Based Enzyme Biocomposites
Chemical Reviews, 2021, Peter Wied, Francesco Carraro
exaly
Bioinspired Framework Catalysts: From Enzyme Immobilization to Biomimetic Catalysis
Chemical Reviews, 2023Kun-Yu Wang, Jiandong Pang, Wei Shi
exaly